Phloroglucinol-Based Cannabinoid Synthesis With Low THC Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing cannabinoids, particularly cannabidiol (CBD), are inefficient, costly, and produce unwanted psychoactive side-products like THC, with complex purification processes and high costs due to the use of expensive reactants and harsh reaction conditions.
Innovation Solution
A stereospecific, cost-effective synthesis method using readily available reactants and mild conditions to produce cannabinoids like CBD and analogs in high yield, minimizing unwanted by-products and enabling a one-pot reaction without intermediate isolation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional extraction and isolation methods are used to obtain CBD from Cannabis sativa, then the CBD can be obtained from natural source, but the process becomes complex and faces quality control challenges due to chemical and physical similarities among phytocannabinoids
Solution Approach 1:
The patent extracts only the necessary CBD molecule from the complex Cannabis sativa source through chemical synthesis, eliminating the need to separate CBD from other similar phytocannabinoids. The synthesis produces pure CBD directly without the contamination risks associated with natural extraction and isolation processes.
2Manufacturing precision
If expensive optically pure reactants are used in stereoselective synthesis, then the desired enantiomer can be produced, but the synthetic process becomes very expensive
Solution Approach 1:
The patent employs inexpensive, readily available starting materials and catalysts to achieve stereoselective synthesis. By using cheap reactants and efficient catalytic systems rather than expensive optically pure compounds, the method maintains high stereoselectivity while dramatically reducing synthesis costs.
Solution Approach 2:
The patent optimizes reaction parameters such as catalyst selection, temperature, and solvent conditions to achieve high stereoselectivity with inexpensive reactants. By carefully controlling reaction conditions, the method obtains the desired enantiomer with high purity without requiring costly starting materials.
3Productivity
If harsh reaction conditions are used in cannabinoid synthesis, then the reaction can proceed effectively, but unwanted psychoactive side-products like THC are produced
Solution Approach 1:
The patent employs mild reaction conditions including lower temperatures, neutral or weakly basic pH environments, and selective catalysts that promote the desired cannabinoid formation while suppressing side reactions. These controlled parameters maintain high reaction efficiency without generating unwanted psychoactive compounds like THC.
Solution Approach 2:
The patent uses specific catalysts and protecting groups as intermediaries to guide the reaction through controlled pathways. These intermediaries enable the synthesis to proceed efficiently under mild conditions while preventing the formation of harmful side-products by blocking alternative reaction routes that would lead to psychoactive compounds.
4Manufacturing precision
If multistep synthesis methods are used to produce CBD, then the desired product can be obtained, but the process requires complex purification and intermediate isolation
Solution Approach 1:
The patent combines multiple synthesis steps into a streamlined sequence where intermediate purification is minimized or eliminated. By designing the synthesis pathway to produce the final product with high selectivity in a connected sequence of reactions, the method achieves complex transformations without requiring complex intermediate isolation and purification operations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high purity and yield of desired cannabinoids with reduced production of psychoactive compounds, simplifying the process and lowering costs, making it suitable for commercial production.
Implementation Method 1
contacting (AA) with a second reactant having the structure of formula (CC-1) in the presence of a Lewis acid catalyst under reaction conditions effective to result in cross-coupling of reactants (AA) and (CC-1)
Data Source
AI summary
Methods are provided for the synthesis of cannabinoids, including cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC), cannabidiolic acid (CBDA), cannabigerol (CBG), cannabigerolic acid (CBGA), cannabidivarin (CBDV), cannabidibutol (CBD-C4), dihydrocannabidiol (DCBD), tetrahydrocannabivarin (THCV), analogs thereof, and precursors to the foregoing. One method employs phloroglucinol or a phloroglucinol analog as a starting material. The syntheses are stereospecific, efficient, selective, and cost-effective, with little or no potential for generation of THC ((−)-trans-Δ9-tetrahydro-cannabinol) or any other psychoactive side product. Telescoped syntheses are also provided, as are new cannabinoids, pharmaceutical formulations, and methods of use.